后来
发表于 2025-3-25 05:18:48
http://reply.papertrans.cn/47/4647/464700/464700_21.png
发炎
发表于 2025-3-25 07:38:04
The New Face of IBD,nt migration studies have demonstrated that when individuals migrate from a region of low-IBD incidence to one of high incidence, the first-generation immigrants continue to remain at a low risk while the risk of IBD in the second-generation immigrants is similar to that of the country of residence
jaundiced
发表于 2025-3-25 15:33:27
http://reply.papertrans.cn/47/4647/464700/464700_23.png
Gorilla
发表于 2025-3-25 16:20:11
Do Genes Matter?,lymorphisms, inadequately powered studies or the heterogeneity of Crohn’s disease cases. A better understanding of gene-environment interactions and their functional consequences may provide important insights. Here we examine the advances made over the past decade and the role that genotyping place
LUMEN
发表于 2025-3-25 20:09:50
http://reply.papertrans.cn/47/4647/464700/464700_25.png
ALIBI
发表于 2025-3-26 02:08:41
http://reply.papertrans.cn/47/4647/464700/464700_26.png
项目
发表于 2025-3-26 04:53:41
IBD Therapies: Coming Attractions,ical phenotype, and treatment responses in patients with IBD, the availability of multiple agents targeting different pathways is likely to lead to improved overall outcomes and change the landscape of treatment recommendations in the next decade.
Glucose
发表于 2025-3-26 11:39:40
The Different Drummer: Non-traditional Therapeutic Approaches,h will further allow practitioners to build trust with patients with IBD and optimize their care. The aim of this review is to present the existing data on probiotics, fecal microbiota transplantation, helminths, herbs and botanicals including cannabis, and mind-body practices as CAM therapy for IBD
idiopathic
发表于 2025-3-26 16:19:38
The Biosimilar Revolution: Coming to an IBD Patient Near You?,treatment of inflammatory bowel disease have been available in Europe and Asia for a few years, and are expected to become available in the USA in 2017–18. In this chapter, we will discuss how biosimilars are approved, the clinical data that have led to the approval of CT-P13 along with available po
abject
发表于 2025-3-26 20:48:28
rdiac structures. While contrast echocardiography has been used to detect the presence of phenomena such as valvular insufficiency and right-to-left shunting across atrial or ventricular septal defects , it can further be used to evaluate abnormal pressure and flow states which may vary even in